Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Boursi

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 14, 2012
Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinomaDaniel Keizman, Maya Ish-Shalom, Roberto Pili, et al.
Cancer Investigation|September 4, 2023
Tumor Differentiation as a Prognostic Marker in Clinically Staged T1bN0 Esophageal AdenocarcinomaOfer Margalit, Einat Shacham-Shmueli, Gal Strauss, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 3, 2022
Pelvic Peritonectomy Poorly Affects Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal MetastasesEyal Mor, Dan Assaf, Shachar Laks, et al.
Annals of Surgical Oncology|August 8, 2022
Natural History and Management of Small-Bowel Obstruction in Patients After Cytoreductive Surgery and Intraperitoneal ChemotherapyEyal Mor, Shanie Shemla, Dan Assaf, et al.
Oncotargets and Therapy|November 25, 2020
Clinical Characteristics and Prognosis of Gastric Cancer Patients with <i>BRCA 1/2</i> Germline Mutations: Report of Ten Cases and a Literature ReviewNaama Halpern, Albert Grinshpun, Ben Boursi, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2025
Mitochondrial DNA lineages determine tumor progression through T cell reactive oxygen signalingTal Yardeni, Arnold Z Olali, Hsiao-Wen Chen, et al.
The Oncologist|December 7, 2013
Active smoking may negatively affect response rate, progression-free survival, and overall survival of patients with metastatic renal cell carcinoma treated with sunitinibDaniel Keizman, Maya Gottfried, Maya Ish-Shalom, et al.
The Oncologist|August 20, 2025
First-line PD-1 +/- CTLA-4 blockade in patients with deficient mismatch repair and/or microsatellite instability-high metastatic colorectal cancerVincenzo Nasca, Gabriele Tinè, Julien Taieb, et al.
The Oncologist|April 14, 2026
Mucinous histology and resistance to immune checkpoint blockade in patients with microsatellite instability-high metastatic colorectal cancerVincenzo Nasca, Margherita Ambrosini, Julien Taieb, et al.
The Israel Medical Association Journal : IMAJ|May 11, 2010
First report of screening an asymptomatic population for cancer: the yield of an integrated cancer prevention centerBen Boursi, Hanan Guzner-Gur, Yaquv Mashich, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
European Journal of Cancer (Oxford, England : 1990)|March 14, 2012
Bisphosphonates combined with sunitinib may improve the response rate, progression free survival and overall survival of patients with bone metastases from renal cell carcinomaDaniel Keizman, Maya Ish-Shalom, Roberto Pili, et al.
Cancer Investigation|September 4, 2023
Tumor Differentiation as a Prognostic Marker in Clinically Staged T1bN0 Esophageal AdenocarcinomaOfer Margalit, Einat Shacham-Shmueli, Gal Strauss, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|November 3, 2022
Pelvic Peritonectomy Poorly Affects Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal MetastasesEyal Mor, Dan Assaf, Shachar Laks, et al.
Annals of Surgical Oncology|August 8, 2022
Natural History and Management of Small-Bowel Obstruction in Patients After Cytoreductive Surgery and Intraperitoneal ChemotherapyEyal Mor, Shanie Shemla, Dan Assaf, et al.
Oncotargets and Therapy|November 25, 2020
Clinical Characteristics and Prognosis of Gastric Cancer Patients with <i>BRCA 1/2</i> Germline Mutations: Report of Ten Cases and a Literature ReviewNaama Halpern, Albert Grinshpun, Ben Boursi, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 3, 2025
Mitochondrial DNA lineages determine tumor progression through T cell reactive oxygen signalingTal Yardeni, Arnold Z Olali, Hsiao-Wen Chen, et al.
The Oncologist|December 7, 2013
Active smoking may negatively affect response rate, progression-free survival, and overall survival of patients with metastatic renal cell carcinoma treated with sunitinibDaniel Keizman, Maya Gottfried, Maya Ish-Shalom, et al.
The Oncologist|August 20, 2025
First-line PD-1 +/- CTLA-4 blockade in patients with deficient mismatch repair and/or microsatellite instability-high metastatic colorectal cancerVincenzo Nasca, Gabriele Tinè, Julien Taieb, et al.
The Oncologist|April 14, 2026
Mucinous histology and resistance to immune checkpoint blockade in patients with microsatellite instability-high metastatic colorectal cancerVincenzo Nasca, Margherita Ambrosini, Julien Taieb, et al.
The Israel Medical Association Journal : IMAJ|May 11, 2010
First report of screening an asymptomatic population for cancer: the yield of an integrated cancer prevention centerBen Boursi, Hanan Guzner-Gur, Yaquv Mashich, et al.
Pageof 11